A Gene-Expression Signature as a Predictor of Survival in Breast CancerMarc J. van de Vijver, René Bernards, Yudong D. He et al.|New England Journal of Medicine|2002Cited by 6.5k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungRobert J.C. Slebos, Sjoerd Rodenhuis, R.E. Kibbelaar et al.|New England Journal of Medicine|1990Cited by 811
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose ChemotherapyFrits S.A.M. van Dam, Sjoerd Rodenhuis, Willem Boogerd et al.|JNCI Journal of the National Cancer Institute|1998Cited by 768
Mutational Activation of the K-<i>ras</i>OncogeneSjoerd Rodenhuis, Johannes L. Bos, Marcus L. van de Wetering et al.|New England Journal of Medicine|1987Cited by 540
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.Sjoerd Rodenhuis, Johannes L. Bos, Robbert J.C. Slebos et al.|PubMed|1988Cited by 464